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Background: Herbal medicines have unique odors, and the act of smelling may have modulatory effects on the
immune system. We investigated the effect of olfactory exposure to Tokishakuyaku-san (TJ-23), a Japanese herbal
medicine, on alloimmune responses in a murine model of cardiac allograft transplantation.
Methods: Naïve or olfactory-dysfunctional CBA mice underwent transplantation of a C57BL/6 heart and were
exposed to the odor of TJ-23 until rejection. Some naïve CBA recipients of an allograft were given olfactory exposure
to Sairei-to (TJ-114), trimethylthiazoline (TMT), individual components of TJ-23, or a TJ-23 preparation lacking one
component. Adoptive transfer studies were performed to determine whether regulatory cells were generated.
Results: Untreated CBA mice rejected their C57BL/6 allografts acutely, as did olfactory-dysfunctional CBA mice exposed
to the odor of TJ-23. CBA recipients of a C57BL/6 heart given olfactory exposure to TJ-23 had significantly prolonged
allograft survival, whereas those exposed to the odor of TJ-114, TMT, one component of TJ-23, or TJ-23 lacking a
component did not. Secondary allograft recipients that were given, at 30 days after transplantation, either whole
splenocytes, CD4+ cells, or CD4+CD25+ cells from primary recipients exposed to the odor of TJ-23 had indefinitely
prolonged allograft survival.
Conclusions: Prolonged survival of cardiac allografts and generation of regulatory cells was associated with
exposure to the odor of TJ-23 in our model. The olfactory area of the brain may have a role in the modulation of
immune responses.
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Brain function might be correlated with immune resposes
[1]. In previous study, we investigated the effects of audi-
tory stimulation of Opera in murine heart transplantation
model and confirmed the correlation. Next to auditory
stimulation of Opera music and sounds, our current study
investigated the effects of olfactory stimulation of herbal
medicines on alloimmune responses in murine heart
transplantation model.
Odors received through the epithelium of the nose are
converted to different topographical maps in the olfac-
tory bulb of the brain and can induce aversion or attrac-
tion [2]. Herbal medicines usually have unique scents,
and exposure to these odors may affect physiologic func-
tions and clinical symptoms. Thus, aromatherapy is used* Correspondence: mniimi@zaf.att.ne.jp
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unless otherwise stated.for pain relief, induction of relaxation, reduction of anx-
iety, and energy enhancement [3]. Moreover, the olfaction
process may have modulatory effects on the immune sys-
tem [4,5]. However, no study has investigated a possible
relationship between smelling and transplantation.
New immunosuppressive drugs have improved allograft
survival rates in patients who have undergone transplant-
ation, but long-term outcomes are compromised by graft
loss due to chronic rejection and the side effects of non-
specific lifelong immunosuppressive therapy, which in-
creases the risk of infection and malignant disease [6-9].
More research is needed on methods for minimizing the
risks associated with transplantation and immunosup-
pressive therapy.
Studies in experimental models have shown that im-
munologic tolerance involves both central and peripheral
mechanisms [10]. Peripheral tolerance can be achieved by
such mechanisms as anergy, deletion, ignorance, and activeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Allograft survival duration in mice given
olfactory exposure to individual components of
Tokishakuyaku-san
Component Individual graft survival (d) MST (d)
Cnidii rhizoma 7, 8, 11, 13, 16 11
Alismatis rhizoma 7, 8, 8, 14, 50 8
Poria sclerotium 7, 8, 8, 9, 10 8
Paeoniae radix 7, 7, 8, 9, 18 8
Angelicae radix 7, 7, 8, 8, 22 8
Atractylodis lanceae rhizome 7, 7, 7, 11, 18 7
MST, median survival time.
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peripheral tolerance, active suppression by regulatory
T cells is likely to have a crucial role in maintaining
tolerance to transplants [13,14]. Once donor-specific
regulatory cells have been induced and survive in the
recipient of a graft, it may be possible to modify the
lifelong use of nonspecific immunosuppressive agents.
Therefore, identification of agents that promote in-
duction and maintenance of regulatory cells may have
implications for the development of new tolerogenic
strategies in transplantation.
Since Japanese government health officials officially
recognized the therapeutic effects of Japanese herbal
medicines about 30 years ago, these agents have been
widely used as alternative therapy for several diseases. We
previously demonstrated the efficacy of several commonly
employed agents in inducing donor-specific regulatory
cells and prolonging allograft survival in mice [15-21]. Li
and Weir [22] showed that Radix Tripterygium wilfordii, a
Chinese herbal medicine, has immunosuppressive effects
in human blood mononuclear cells in vitro. In recent
studies in our murine model, oral administration of
the Japanese herbal medicines Sairei-to (TJ-114) [23],
Tokishakuyaku-san (TJ-23) [24], or Artemisiae Capillaris
Herba [25] was associated with significantly prolonged
survival of allogeneic cardiac grafts and generation of
regulatory cells. In the current study, we examined
whether olfactory exposure to TJ-23 affected duration
of allograft survival in the same model.
Methods
Mice
Male C57BL/6 (B6, H2b), CBA (H2k), and BALB/c (H2d)
mice that were 8 to 12 weeks of age were purchased
from Sankyo Ltd (Tokyo, Japan). CBA mice with olfac-
tory dysfunction induced by excision of the olfactory
bulb in a stereotaxic procedure were purchased from
Charles River Laboratories (Tokyo). All mice were
housed in conventional facilities at the Biomedical
Services Unit of Teikyo University and used in accord-
ance with the guidelines for animal experimentation
approved by the Animal Use and Care Committee of
Teikyo University.
Heart transplantation
All transplant procedures were performed with the mice
under general anesthesia. Fully vascularized heterotopic
hearts from B6 or BALB/c donors were transplanted
into CBA mice by using microsurgical techniques [26].
Postoperatively, graft function was assessed daily by
palpation for evidence of contraction. Rejection was
defined as complete cessation of the heartbeat and
confirmed by direct visualization and histologic exam-
ination of the graft.Exposure to odors
To accomplish exposure to the odor of an agent, 12.5 g
of the agent was added to 500 mL of water in an electric
pot placed in a chamber and the mixture was boiled
intermittently so that a temperature of 28°C to 30°C and
a relatively humidity level of 60% was maintained in the
chamber. The agent/water mixture was changed at the
same time every day. CBA recipients of a B6 heart were
put into the chamber from the day of transplantation
until rejection. Within the chamber, mice underwent olfac-
tory exposure to one of the following: water vapor alone
(control group); TJ-23; TJ-114; trimethylthiazoline (TMT),
which is secreted from the anal gland of fox and induces
aversive behavior and fear responses in mice [2]; a mixture
of TJ-23 and TMT; each component (Table 1) of TJ-23; or
a preparation of TJ-23 from which one of its six compo-
nents had been removed (Table 2). Olfactory-dysfunctional
CBA and olfactory bulb sham-operated CBA recipients of
a B6 heart were exposed to the odor of TJ-23. All herbal
medicines were gifts from Tsumura (Tokyo, Japan).
Adoptive transfer studies
Adoptive transfer studies were conducted to determine
whether regulatory cells were generated by olfactory
exposure to TJ-23. Thus, 30 days after CBA recipients
(primary recipients) underwent transplantation of a B6
cardiac allograft and were exposed to the odor of TJ-23,
splenocytes (5.0 × 107) from primary recipients with
functioning allografts were adoptively transferred into naive
CBA mice (secondary recipients). After the adoptive trans-
fer, the secondary recipients underwent transplantation of a
B6 or BALB/c heart immediately. In some experiments,
CD4+ and CD4+CD25+ cells were purified from the spleens
of primary transplant recipients exposed to the odor of
TJ-23 by positive selection using a magnetically activated cell
sorter (MACS), CD4 microbeads (Miltenyi Biotec, Auburn,
CA; purity > 98%), and mouse CD4+ CD25+ regulatory
T-cell isolation kit (Miltenyi Biotec). 2.0 × 107 of the CD4+
cells or 1.0 × 106 of the CD4+CD25+ cells were adoptively
transferred into naïve secondary recipients, which then
immediately underwent transplantation of a B6 heart.
Table 2 Allograft survival duration in mice given
olfactory exposure to either Tokishakuyaku-san with one
component removed or to water vapor
Component removed/water vapor Individual graft
survival (d)
MST (d)
Alismatis rhizoma 6, 10, 21, 37, 48 21
Atractylodis lanceae rhizome 7, 9, 13, 16, 19 13
Angelicae radix 7, 9, 12, 14, 16 12
Paeoniae radix 7, 7, 10, 19, 26 10
Cnidii rhizoma 7, 8, 8, 8, 28 8
Poria sclerotium 7, 7, 8, 8, 12 8
Water 6, 6, 6, 7, 8, 9, 9, 16, 20, 20 8.5
MST, median survival time.
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Cardiac allografts in untreated mice and mice exposed
to the odor of TJ-23 were removed 30 days after trans-
plantation and studied immunohistochemically with use
of double immunostaining. Fresh 4-μm-thick graft cryo-
sections were fixed in ice-cold acetone and preincu-
bated in Block Ace (Dainippon Pharmaceutical Co., Ltd,
Tokyo, Japan). Samples were incubated with anti-Foxp3
(kindly provided by Professor Kenjiro Matsuno, Dokkyo
Medical University, Tochigi, Japan) polyclonal antibody;
incubated with alkaline phosphatase (ALP)-conjugated
anti-rabbit Ig (712-055-152; Jackson ImmunoResearch
Laboratories, West Grove, PA, USA) for anti-Foxp3; and
developed blue with Vector Blue (Vector Laboratories,
Burlingame, CA). Cryosections were then incubated with
rabbit anti-mouse type IV collagen polyclonal antibody
(LB1403; Cosmo Bio, Tokyo) and peroxidase-conjugated
anti-rabbit Ig (55693; Mitsubishi Chemical, Tokyo) and
then developed brown with diaminobenzidine (Vector
Laboratories).
Cardiac allografts in untreated mice and mice ex-
posed to the odor of TJ-23 were removed 30 days after
transplantation and studied histologically. Frozen sec-
tions (4-μm thick) were cut, mounted on silane-coated
slides, and stained with hematoxylin-eosin.
Flow cytometry analysis
Thirty days after cardiac allograft transplantation, splenocytes
from recipients exposed to the odor of TJ-23 and un-
treated recipients were stained with fluorochrome-
conjugated anti-CD4 or anti-CD25 monoclonal antibody
(mAb) (RM4-5 and PC61, respectively; BD Biosciences,
San Jose, CA, USA) and antimouse Foxp3 mAb (FJK-
16s; eBioscience, San Diego, CA), as well as their isotype
controls (eBioscience). The stained cells were analyzed
by using a FACS Canto2 system (BD Biosciences), and
the percentage of CD4+CD25+Foxp3+ in CD4+ cells
was determined.Mixed leukocyte culture (MLC) studies and cytokine assays
In MLC studies [27], the responder cells were splenocytes
from naïve CBA mice, untreated mice, or CBA mice ex-
posed to the odor of TJ-23 that had undergone trans-
plantation of a B6 heart 14 days earlier. Proliferation
was assessed by using an Enzyme-linked Immunosorbent
Assays (ELISA) for bromodeoxyuridine incorporation
(Biotrak, version 2, Amersham, Little Chalfont, United
Kingdom [UK]) according to the manufacturer’s in-
structions. MLC studies were performed as described
previously [25].
Enzyme-linked immunoabsorbent assays (ELISAs) were
performed as described previously [25] to assess plasma
levels of interleukin (IL)-2, IL-4, IL-10, and interferon
(IFN)-γ in the supernatant of the MLC on day 4.
Statistical analysis
Cardiac allograft survival in groups of mice was compared
by using Mann-Whitney U tests (Graphpad Prism; San
Diego, CA, USA). In the cell-proliferation, cytokine studies,
and flow cytometry studies, two groups were compared by
using unpaired Student t tests (Graphpad Prism). A P value
of less than 0.05 was considered to represent a significant
difference between groups.
Results
Effect of various odors on survival of cardiac allografts
Our previous studies showed that the majority of CBA
recipients given oral administration of TJ-114 and TJ-23
indefinitely prolonged cardiac allograft survival while un-
treated recipients rejected allograft acutely (median survival
times [MSTs], >100, >100 and 7days, respectively; P < 0.01;
Figure 1A).
CBA mice that were given a B6 cardiac graft and under-
went olfactory exposure to either water vapor or TJ-114
rejected their allografts acutely (MST, 8.5 days for both ex-
posures; Figure 1B). In contrast, allografts in mice exposed
to the odor of TJ-23 had significantly prolonged survival
duration (MST, 48 days; individual allograft survival times,
9, 10, 14, 48, > 100, > 100, and > 100 days; P < 0.05 vs either
the water-exposed or TJ-114-exposed group; Figure 1B).
None of the individual components of TJ-23 had this effect
(Table 1), nor did any of the preparations of TJ-23 with one
component removed (Table 2).
CBA recipients of allografts that were exposed to the odor
of TMT (fox smell) rejected their grafts acutely (MST, 8
days; P < 0.01 vs TJ-23-exposed group; Figure 1C), whereas
those exposed to a mixture of the odors of TJ-23 and TMT
had significantly shorter allograft survival compared with
the TJ-23-exposed group (MST, 9 days; P < 0.05; Figure 1C).
Effect of olfactory dysfunction on allograft survival
CBA mice in which the olfactory bulb had been excised
rejected their B6 grafts acutely, even if they had been
Figure 1 Allograft survival of CBA mice given oral administration or exposed to various odors of Japanese Herbal Medicines and
histologic findings in CBA mice. (A) Results in recipients of a C57BL/6 heart that were untreated or given oral administration of TJ-23 and
TJ-114 from the day of transplantation until 7 days afterward. MST, median survival time; *P < 0.01 for difference between 2 groups. (B) Results in
recipients of a C57BL/6 heart that were exposed to either water vapor alone or to the odors of TJ-23 and TJ-114 from the day of transplantation
until allograft rejection. MST, median survival time; #P < 0.05 for difference between two groups. (C) Results in recipients of a C57BL/6 heart that
were exposed to the odor of TJ-23, trimethylthiazoline (TMT), or both agents from the day of transplantation until allograft rejection. MST,
median survival time; #P < 0.05 and *P < 0.01 for difference between two groups. (D) Results in naïve, olfactory bulb sham-operated and
olfactory-dysfunctional CBA recipients of a C57BL/6 heart exposed to the odor of TJ-23 and in olfactory-dysfunctional CBA recipients with
no exposure. Mice were treated from the day of transplantation until allograft rejection. MST, median survival time; *P < 0.01 and #P < 0.05
for difference between two groups. (E) Histologic studies of cardiac allografts obtained from mice given olfactory exposure to TJ-23 and
untreated mice (hematoxylin and eosin stain; magnification × 40).
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untreated and TJ-23-exposed mice; P < 0.01 vs naïve
TJ-23-exposed mice for both comparisons; Figure 1D).
When B6 hearts were transplanted into olfactory bulb
sham-operated CBA mice exposed to the odor of TJ-
23, the allograft survival was prolonged significantly
(MST, 30 days; P < 0.05 vs untreated and TJ-23-exposed
olfactory dysfunction mice).
Histologic features of allografts
Histologic examinations of cardiac allografts obtained 30
days after transplantation from mice given olfactory ex-
posure to TJ-23 showed some cell infiltration, preserved
graft structure, and mild myocardial injuries. Allografts
from untreated recipients showed severe myocyte damage,
edema, and aggressive cell infiltration characteristic of the
acute rejection process (Figure 1E).Generation of regulatory cells in mice given olfactory
exposure to TJ-23
In the adoptive transfer studies, secondary CBA recipients
of a B6 heart that were given whole splenocytes from
primary TJ-23-exposed CBA recipients of a B6 cardiac
graft 30 days after grafting had indefinitely prolonged
survival of their allografts (MST, > 100 days; Figure 2A).
The MSTs of allografts in secondary recipients given
splenocytes from either naïve CBA mice or from third-
party (BALB/c) mice were significantly shorter (MST,
12 and 13 days, respectively; P < 0.01 vs TJ-23-exposed
secondary recipients; Figure 2A).
Secondary CBA recipients of a B6 heart that were given
either CD4+ or CD4+CD25+ cells purified from the spleens
of primary TJ-23-exposed CBA recipients of a B6 heart
had indefinitely prolonged survival of their allografts
(MST, > 100 days for each cell type; P < 0.01 vs both CD4+
Figure 2 Evidence of generation of regulatory cells in CBA recipients of cardiac allografts given olfactory exposure to TJ-23. Allograft
survival times after adoptive transfer of whole splenocytes (A), CD4+ splenocytes (B), or CD4+CD25+ splenocytes (C). MST, median survival
time; *P < 0.01 for difference between two groups. (D) CD4, CD25, and Foxp3 expression in splenocytes, as determined by flow cytometry. Data
are mean ± SD values for the percentage of CD4+CD25+Foxp3+ in CD4+ cells in samples from five mice in each group. *P < 0.01 for difference
between 2 groups. (E) Foxp3+ cells detected by double immunostaining in cardiac allografts obtained 30 days after transplantation from mice
given olfactory exposure to TJ-23 and untreated mice (magnification × 40).
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naïve CBA mice]; Figure 2B and 2C). In contrast, the MST
of B6 allografts in secondary CBA recipients that under-
went adoptive transfer of either CD4+ or CD4+CD25+ cells
from the spleens of naïve CBA mice was 8 days. These
data indicate that olfactory exposure to TJ-23 generated
regulatory cells which might be donor specific in the pri-
mary recipients and that one of the regulatory populations
consisted of CD4+CD25+ cells.
Flow cytometry studies showed that the population of
CD4+CD25+Foxp3+ cells in the CD4+ cells was increased in
the spleens of CBA recipients of allografts exposed to the
odor of TJ-23 compared with those of untreated recipients
(P < 0.01; Figure 2D). Immunohistochemical studies showed
that cardiac allografts from TJ-23-exposed recipients
had more Foxp3+ cells than those from untreated mice
(Figure 2E). These data suggest that the CD4+ regulatory
cells contained a population that was CD4+CD25+Foxp3+.
Cell proliferation and cytokine production in mice given
olfactory exposure to TJ-23
Maximum proliferation of naïve CBA splenocytes
(responder cells) against B6 splenocytes (stimulator cells)treated with mitomycin C occurred on day 4 of the MLCs.
Proliferation of splenocytes from CBA recipients of al-
lografts given olfactory exposure to TJ-23 was signifi-
cantly suppressed compared with that of splenocytes
from untreated recipients (Figure 3A; P < 0.01).
Levels of interleukin IL-2 (Figure 3B) and IFN-γ
(Figure 3C) in splenocytes from allograft recipients ex-
posed to the odor of TJ-23 were significantly lower than
those in splenocytes from recipients not exposed to TJ-23,
whereas levels of IL-10 (Figure 3D) were higher. There
was no difference between the two groups in levels of IL-4
(data not shown).
Discussion
In this study, we found that olfactory exposure to TJ-
23—but not to a component of TJ-23, a preparation of
TJ-23 with one component missing, or both TJ-23 and fox
smell—induced hyporesponsiveness to fully mismatched
cardiac allografts in mice. The increase in the duration
of allograft survival has several possible mechanisms. One
is that exposure to the odor of TJ-23 generated regula-
tory cells. Active suppression by regulatory cells has
been found to be an important mechanism of induction
Figure 3 Evidence of induction of alloproliferative hyporesponsiveness in CBA recipients of allograft exposed to the odor of TJ-23. (A)
Results of cell-proliferation assays in mixed leukocyte cultures (MLCs). Data are mean ± SD values derived from samples from five mice in each
group. *P < 0.01 for difference between two groups. Levels of interleukin (IL)-2 (B), interferon (IFN)-γ (C), and IL-10 (D) in the MLCs, as assessed by
enzyme-linked immunosorbent assays. Data are shown as mean ± SD values derived from samples from five mice in each group. #P < 0.05 and *P< 0.01
for difference between two groups.
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to allografts [11], and prevention of vasculopathy in cardiac
allografts [35,36]. In our study, adoptive transfer of whole
splenocytes from primary CBA recipients given olfactory
exposure to TJ-23 induced indefinitely prolonged survival
of B6 cardiac allografts in secondary recipients, whereas
secondary CBA recipients of a B6 heart given splenocytes
from BALB/c mice rejected their allografts acutely. These
findings indicate that the exposure to TJ-23 generated regu-
latory cells that may have been donor specific. In addition,
adoptive transfer of CD4+ or CD4+CD25+ splenocytes from
primary recipients exposed to the odor of TJ-23 induced
indefinitely prolonged survival of allografts in secondary
recipients. Moreover, flow cytometry analysis found that
the percentage of CD4+CD25+Foxp3+ cells in CD4+ cells
was increased in TJ-23-exposed allograft recipients com-
pared with untreated recipients. These results confirmed
that the regulatory population generated by olfactory
exposure to TJ-23 contained CD4+CD25+ cells.
A second possible mechanism for the effects produced
by olfactory exposure to TJ-23 was that the treatmentchanged the balance between Th-1 and Th-2 cytokines.
In TJ-23-exposed mice, the expression of Th-1 cytokines
(IL-2 and IFN-γ) was decreased and that of a Th-2 cytokine
(IL-10) was increased. IL-10 promotes generation of regu-
latory T cells in vivo [37] and is required for regulatory
T cells to mediate tolerance to alloantigens [38]. Moreover,
alloantigen-specific regulatory T cells have been shown to
prevent rejection of transplanted organs that is initiated
by CD4+CD25+ T cells [39,40]. Therefore, we suggest that
olfactory exposure to TJ-23, which suppressed production
of Th1 cytokines in our model, may have protected
myocardial cells and induced CD4+CD25+ regulatory
cells by means of up-regulation of Th2 cytokines.
A third mechanism for the prolongation of allograft sur-
vival (MST, 48 days) in our model may have been that the
unique odor of TJ-23 affected the brain through the olfac-
tory function, thereby modulating the immune system of
the transplant recipients. We have already assumed the
correlation between stimulation to brain and immune
system, and we have demonstrated that auditory stimula-
tion through the brain can induce prolongation of allograft
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cells [1]. In the current study, olfactory-dysfunctional mice
exposed to the odor of TJ-23 rejected their grafts acutely
(MST, 7 days), however, naïve and olfactory bulb sham-
operated CBA mice exposed to the odor of TJ-23 prolonged
the allograft survival significantly (MSTs, 48 and 30 days),
indicates that the olfactory area of the brain may play an
important role in modulation of immune responses. On the
other hand, adding the odor of TMT (fox smell) to that
of TJ-23 attenuated the prolongation of TJ-23-induced
allograft survival (MST, 9 days). Therefore, exposure to the
unique odor of TJ-23—but not to a component of TJ-23 or
a preparation of TJ-23 with one component missing—may
be necessary to induce hyporesponsiveness to fully mis-
matched cardiac allografts, and the addition of TMT also
changes the odor in chamber, results in attenuation of ef-
fect on allograft survival.
Finally, the hyporesponsiveness in our model may have
resulted from absorption of TJ-23 directly through the
respiratory tract or skin rather than via the brain. How-
ever, if the effects observed in TJ-23-exposed mice had
resulted from transtracheal or percutaneous exposure to
TJ-23, our findings with respect to allograft survival in
olfactory-dysfunctional recipients would probably have
been similar to those in allograft recipients with a nor-
mal sense of smell.
Conclusions
These findings demonstrated that olfactory exposure to
TJ-23 induced prolongation of B6 cardiac graft survival
and generated CD4+CD25+Foxp3+ regulatory cells in
naïve CBA mice but not in CBA mice with olfactory dys-
function. There may be relationships among the unique
odor TJ-23; brain function, including olfactory function;
and the immune system.
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